Left ventricular diastolic dysfunction, the main feature of heart failure with preserved ejection fraction (HFpEF), is thought to be primarily caused by comorbidities affecting the endothelial function of the coronary microvasculature. Circulating extracellular vesicles, released by the endothelium have been postulated to reflect endothelial damage. Therefore, we reviewed the role of extracellular vesicles, in particularly endothelium microparticles, in these comorbidities, including obesity and hypertension, to identify if they may be potential markers of the endothelial dysfunction underlying left ventricular diastolic dysfunction and HFpEF
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Over the past decade, myocardial structure, cardiomyocyte function, and intramyocardial signaling we...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Left ventricular diastolic dysfunction, the main feature of heart failure with preserved ejection fr...
Left ventricular diastolic dysfunction, the main feature of heart failure with preserved ejection fr...
Heart failure with preserved ejection fraction (HFpEF) has been recognized as the greatest single un...
While endothelial dysfunction is suggested to contribute to heart failure with preserved ejection fr...
Heart failure with preserved ejection fraction (HFpEF) is a complex heterogeneous disease for which ...
AimsExtracellular vesicles (EVs) were investigated as potential biomarkers associated with heart fai...
OBJECTIVES: The present study investigated whether systemic, low-grade inflammation of metabolic ris...
AimsExtracellular vesicles (EVs) were investigated as potential biomarkers associated with heart fai...
Heart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern ...
Heart failure with preserved ejection fraction (HFpEF) is an increasingly studied entity accounting ...
Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) wit...
Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) wit...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Over the past decade, myocardial structure, cardiomyocyte function, and intramyocardial signaling we...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Left ventricular diastolic dysfunction, the main feature of heart failure with preserved ejection fr...
Left ventricular diastolic dysfunction, the main feature of heart failure with preserved ejection fr...
Heart failure with preserved ejection fraction (HFpEF) has been recognized as the greatest single un...
While endothelial dysfunction is suggested to contribute to heart failure with preserved ejection fr...
Heart failure with preserved ejection fraction (HFpEF) is a complex heterogeneous disease for which ...
AimsExtracellular vesicles (EVs) were investigated as potential biomarkers associated with heart fai...
OBJECTIVES: The present study investigated whether systemic, low-grade inflammation of metabolic ris...
AimsExtracellular vesicles (EVs) were investigated as potential biomarkers associated with heart fai...
Heart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern ...
Heart failure with preserved ejection fraction (HFpEF) is an increasingly studied entity accounting ...
Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) wit...
Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) wit...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Over the past decade, myocardial structure, cardiomyocyte function, and intramyocardial signaling we...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...